Literature DB >> 27626529

Danazol Treatment for Telomere Diseases.

Mathis Grossmann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27626529     DOI： 10.1056/NEJMc1607752

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita.

Authors:  Payal P Khincha; Alison A Bertuch; Shahinaz M Gadalla; Neelam Giri; Blanche P Alter; Sharon A Savage
Journal:  Blood Adv       Date:  2018-06-12

2.  Correlation of human telomerase reverse transcriptase single nucleotide polymorphisms with in vitro fertilisation outcomes.

Authors:  Kailing Dai; Hongmei Xu; Nengyong Ouyang; Ying Li; Ping Yuan; Liangan Wang; Xiaomiao Zhao; Wenjun Wang
Journal:  J Assist Reprod Genet       Date:  2018-12-10       Impact factor: 3.412

Review 3.  An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.

Authors:  Marena R Niewisch; Sharon A Savage
Journal:  Expert Rev Hematol       Date:  2019-09-10       Impact factor: 2.819

Review 4.  Telomeres and Telomerase in Hematopoietic Dysfunction: Prognostic Implications and Pharmacological Interventions.

Authors:  Theresa Vasko; Andrea Kaifie; Matthias B Stope; Thomas Kraus; Patrick Ziegler
Journal:  Int J Mol Sci       Date:  2017-10-28       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.